Preventing the next pandemics

As we approach the end of 2021, the prevention agenda has become more relevant than ever.
Has the pandemic set public health back? Can we do better? Better risk prediction, better prevention interventions, better distribution of funding and use of technologies to solve the problems we are facing?
How can we think creatively to reimagine public health and what will we be saying about progress in 10 years’ time?

FACILITATED BY

TAMSIN BERRY | Director | PHP

PANELLISTS INCLUDE

MARTIN LUSH | Global Vice President, Pharma Biotech and Medical Devices | NSF Health Sciences
MIKE TRENELL | Chief Executive Officer | Changing Health
RICHARD TORBETT | Chief Executive Officer | ABPI
KATHERINE STUELAND | President And Chief Executive Officer | GeneDX
JOHN DEANFIELD CBE | Professor of Cardiology | University College London